All Research
    PAPER DHA-ALCohort Study

    Circulating Docosahexaenoic Acid and Risk of All-Cause and Cause-Specific Mortality

    Prospective analysis associating higher circulating DHA with lower all-cause mortality (~21% lower comparing highest vs lowest quintile).

    Evidence

    —

    Not Rated

    Sample

    —

    subjects

    Duration

    —

    study period

    Journal

    Mayo Clinic Proceedings

    03

    Structured Methods

    Study Design
    Cohort Study
    Sample Size
    Not reported
    Study Duration
    Not reported
    Methodology
    Not reported
    Limitations
    Not reported
    04

    Citations & References

    Cite this paper

    Unknown authors (n.d.). Circulating Docosahexaenoic Acid and Risk of All-Cause and Cause-Specific Mortality. Mayo Clinic Proceedings.

    Source

    Publisher

    Journal

    Mayo Clinic Proceedings

    05

    Indexing

    Biomarkers

    omega-3-index
    PHS
    671
    / 1000
    T3
    Longevity Operator

    Sample member

    Longevity Operator

    The Peak Human Score · PHS v1

    One number for your longevity journey.

    FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.

    • Metabolic
    • Hormonal
    • Cardiovascular
    • Brain / Cognitive
    • Sleep
    • Musculoskeletal
    • Gut
    • Immunity / Inflammation